Literature DB >> 16966175

Recrudescent cryptococcosis, caused by Cryptococcus gattii (molecular type VGII), over a 13-year period in a Birman cat.

E K Kluger1, H K Karaoglu, M B Krockenberger, P K Della Torre, W Meyer, R Malik.   

Abstract

A 17-year-old desexed male Birman cat presented with a fleshy mass protruding from the left ear canal. A culture from the mass revealed a heavy growth of Cryptococcus gattii (molecular type VGII, serotype B). The lesion resolved with antifungal therapy over 8 weeks. Itraconazole was continued indefinitely due to persistent high serum cryptococcal antigen titres. The cat was euthanased 12 months later due to the acute development of hindlimb ataxia and collapse which may or may not have been attributable to cryptococcosis. This cat had first presented when 4 years of age with a 3-week history of inappetance, sneezing and serous nasal discharge. Culture of swabs from both nostrils were positive for C. gattii (VGII). Fluconazole therapy produced steady improvement over a 6 month period, at which time therapy was discontinued. The cat presented 9 months later for sneezing, again with a positive culture of C. gattii from the nasal cavity. Antifungal therapy was continued for 8 months, after which time cultures were negative and symptoms resolved. Three episodes of cryptococcosis in a cat over a 13-year period were thus documented. Importantly, the two C. gattii isolates, obtained 13 years apart, were identical using DNA fingerprinting and random amplification of polymorphic DNA (RAPD) analysis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16966175     DOI: 10.1080/13693780600582847

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  9 in total

Review 1.  Cryptococcus gattii infections.

Authors:  Sharon C-A Chen; Wieland Meyer; Tania C Sorrell
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

Review 2.  Cryptococcus gattii: an emerging fungal pathogen infecting humans and animals.

Authors:  Edmond J Byrnes; Karen H Bartlett; John R Perfect; Joseph Heitman
Journal:  Microbes Infect       Date:  2011-06-01       Impact factor: 2.700

Review 3.  Cryptococcus gattii comparative genomics and transcriptomics: a NIH/NIAID White Paper.

Authors:  V Chaturvedi; W C Nierman
Journal:  Mycopathologia       Date:  2011-12-17       Impact factor: 2.574

4.  Feline nasal granuloma due to Cryptoccocus gattii type VGII.

Authors:  Pedro Henrique Magalhães Cardoso; Francisco de Assis Baroni; Eriques Gonçalves Silva; Diana Costa Nascimento; Marilena Dos Anjos Martins; Walderez Szezs; Claudete Rodrigues Paula
Journal:  Mycopathologia       Date:  2013-08-13       Impact factor: 2.574

5.  MALDI-TOF MS enables the rapid identification of the major molecular types within the Cryptococcus neoformans/C. gattii species complex.

Authors:  Carolina Firacative; Luciana Trilles; Wieland Meyer
Journal:  PLoS One       Date:  2012-05-29       Impact factor: 3.240

Review 6.  Pathogen and host genetics underpinning cryptococcal disease.

Authors:  Carolina Coelho; Rhys A Farrer
Journal:  Adv Genet       Date:  2020-03-18       Impact factor: 3.880

7.  Otogenic meningoencephalomyelitis due to Cryptococcus gattii (VGII) infection in a cat from Western Australia.

Authors:  Meng K Siak; Amanada Paul; Randi Drees; Ian Arthur; Amanda K Burrows; Anna J Tebb; Richard Malik
Journal:  JFMS Open Rep       Date:  2015-06-01

8.  Nasopharyngeal cryptococcosis in a cat: interlaboratory variation in cryptococcal antigen assay test results.

Authors:  Stephanie A McEwan; Jane E Sykes
Journal:  JFMS Open Rep       Date:  2022-03-25

Review 9.  Global Molecular Epidemiology of Cryptococcus neoformans and Cryptococcus gattii: An Atlas of the Molecular Types.

Authors:  Massimo Cogliati
Journal:  Scientifica (Cairo)       Date:  2013-01-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.